Susceptibilities of Neisseria gonorrhoeae and Ureaplasma urealyticum isolates from male patients with urethritis to several antibiotics including telithromycin

被引:4
作者
Aydin, D [1 ]
Küçükbasmaci, Ö
Gönüllü, N
Aktas, Z
机构
[1] Istanbul Univ, Istanbul Fac Med, Dept Microbiol & Clin Microbiol, TR-34390 Capa, Turkey
[2] Istanbul Univ, Expt Med Res Inst, TR-34390 Capa, Turkey
关键词
minimal inhibitory concentrations; Neisseria gonorrhoeae; Ureaplasma urealyticum; urethritis;
D O I
10.1159/000085616
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The minimal inhibitory concentrations (MICs) of erythromycin, azithromycin, clarithromycin, telithromycin, tetracycline, doxycycline, ciprofloxacin, ofloxacin, norfloxacin, levofloxacin, gemifloxacin and moxifloxacin against 78 Neisseria gonorrhoeae and 31 Ureaplasma urealyticum strains, which were isolated from patients with urethritis in Istanbul, were determined and compared. Additionally, the activities of penicillin and ceftriaxone against N. gonorrhoeae strains were explored. Methods: MICs were determined by agar and broth dilution methods for N. gonorrhoeae and U. urealyticum, respectively. Results: The susceptibility rates for penicillin and tetracycline in N. gonorrhoeae strains were 35.9 and 24.3%, respectively. All gonococcal strains were susceptible to ceftriaxone, with very low MICs ( MIC90 0.008 mu g/ml). Telithromycin was highly active against N. gonorrhoeae and U. urealyticum strains ( MIC90 0.25 mu g/ml for both). Ciprofloxacin was the most active quinolone against N. gonorrhoeae (MIC90 0.008 mu g/ml) while quinolone resistance was detected in a single strain (1.3%). Conclusions: Tetracycline and penicillin should not be the option in empirical treatment of N. gonorrhoeae infections due to the very low susceptibility rates. Ceftriaxone continues to be the first choice antibiotic in the treatment of gonococcal urethritis. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:89 / 92
页数:4
相关论文
共 15 条
[1]  
[Anonymous], 2002, M100S12 NCCLS
[2]   Bacterial pathogens in male patients with urethritis in Istanbul [J].
Aydin, MD ;
Agacfidan, A ;
Güvener, Z ;
Kadioglu, A ;
Ang, O .
SEXUALLY TRANSMITTED DISEASES, 1998, 25 (08) :448-449
[3]   In-vitro activity of ketolides against mycoplasmas [J].
Bebear, CM ;
Renaudin, H ;
Aydin, MD ;
Chantot, JF ;
Bebear, C .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 (05) :669-670
[4]   Anti-gonococcal activity of gemifloxacin against fluoroquinolone-resistant strains and a comparison of agar dilution and Etest methods [J].
Jones, RN ;
Deshpande, LM ;
Erwin, ME ;
Barrett, MS ;
Beach, ML .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 :67-70
[5]  
Knapp JS, 1999, MANUAL CLIN MICROBIO, P586
[6]   PENICILLINASE-PRODUCING NEISSERIA-GONORRHEA STRAINS IN EAST BLACK-SEA REGION OF TURKEY [J].
KOKSAL, I ;
OZGUR, G ;
PISKIN, B .
INFECTION, 1990, 18 (06) :396-396
[7]   In vitro and in vivo antibacterial activities of telithromycin [J].
Mikamo, H ;
Yin, XH ;
Ninomiya, M ;
Tamaya, T .
CHEMOTHERAPY, 2003, 49 (1-2) :62-65
[8]  
National Committee for Clinical Laboratory Standards, 2000, M7A5 NCCLS, VM100-S10
[9]   Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Germany and activity of the ketolide telithromycin: Results from the PROTEKT surveillance study (1999-2000) [J].
Reinert, RR ;
Rodloff, AC ;
Halle, E ;
Baer, W ;
Beyreiss, B ;
Seifert, H ;
Wichelhaus, TA ;
Maass, M ;
Mehl, M .
CHEMOTHERAPY, 2004, 50 (03) :143-151
[10]   In vitro activities of ketolides HRM 3647 and HRM 3004, levofloxacin, and other quinolones and macrolides.: Against Neisseria spp. and Moraxella catarrhalis [J].
Sáez-Nieto, JA ;
Vázquez, JA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (04) :983-984